Abstract
A procedure for the synthesis of 2-anilino-6-hydroxy-3-phenylpyrimidin-4(3H)-one (mafedine) without using alkali metal ethoxides has been developed and optimized. Mafedine-related compounds that can be formed as possible impurities have been prepared, and conditions for joint determination of these impurities by HPLC with spectrophotometric detection have been found. The structure of the mafedine decomposition product in solution has been identified by HPLC-ESI/MS.
Similar content being viewed by others
REFERENCES
Kumar, S. and Narasimhan, B., Chem. Cent. J., 2018, vol. 12, p. 38. https://doi.org/10.1186/s13065-018-0406-5
Roopan, S.M. and Sompalle, R., Synth. Commun., 2016, vol. 46, no. 8, p. 645. https://doi.org/10.1080/00397911.2016.1165254
Zhuang, J. and Ma, S., ChemMedChem, 2020, vol. 15, p. 1875. https://doi.org/10.1002/cmdc.202000378
Sysoev, Yu.I., Whaley, A.K., Prikhodko, V.A., Semivelichenko, E.D., Eletskaya, E.I., Luzhanin, V.G., and Okovityi, S.V., Pharm. Chem. J., 2021, vol. 54, no. 12, p. 1193. https://doi.org/10.1007/s11094-021-02342-y
Sysoev, Yu.I., Meshalkina, D.A., Petrov, D.V., Okovityi, S.V., Musienko, P.E., and Kalueff, A.V., Neurosci. Lett., 2019, vol. 701, p. 234. https://doi.org/10.1016/j.neulet.2019.03.001
Skinner, G.S., Reneberger, J.M., and Vogt, H.C., J. Am. Chem. Soc., 1957, vol. 79, p. 6207. https://doi.org/10.1021/ja01580a027
Krasnov, K.A. and Slesarev, V.I., Russ. J. Org. Chem., 1997, vol. 33, no. 4, p. 543.
Yuskovets, V.N., Chernov, N.M., Yakovlev, I.P., Okovityi, S.V., Sysoev, Yu.I., and Anisimova, N.A., RU Patent no. 2669555, 2018.
Mironov, A.N., Bondarev, V.P., Bunyatyan, N.D., Vasil’ev, A.N., Kukes, V.G., Lepakhin, V.K., Medunitsyn, N.V., Merkulov, V.A., and Sakaeva, I.V., Rukovodstvo po ekspertize lekarstvennykh sredstv (A Guide to Drug Assay), Moscow: Grif i K., 2013, vol. 2.
Impurities in New Drug Substances Q3A (R2). International Conference on Harmonisation (ICH). London, 2006.
Dolomanov, O.V., Bourhis, L.J., Gildea, R.J., Howard, J.A.K., and Puschmann, H., J. Appl. Crystallogr., 2009, vol. 42, p. 339. https://doi.org/10.1107/S0021889808042726
Sheldrick, G.M., Acta Crystallogr., Sect. A, 2008, vol. 64, p. 112. https://doi.org/10.1107/S0108767307043930
Sheldrick, G.M., Acta Crystallogr., Sect. C, 2015, vol. 71, p. 3. https://doi.org/10.1107/S2053229614024218
Funding
Optimization of the synthesis of compound 1 and the syntheses of 4–6 were carried out in the framework of state assignment no. AAAA-A20-120121790030-8. The analytical part of the study was performed using the facilities of the Analytical Center at the St. Petersburg Chemical Pharmaceutical University (Ministry of Health of the Russian Federation) according to project nos. 075-15-2021-685 and 112-2019-0003 under financial support by the Ministry of Science and Higher Education of the Russian Federation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
No conflict of interest was declared by the authors.
Additional information
Translated from Zhurnal Obshchei Khimii, 2021, Vol. 91, No. 9, pp. 1375–1381 https://doi.org/10.31857/S0044460X21090080.
Supplementary information
Rights and permissions
About this article
Cite this article
Sipkina, N.Y., Yuskovets, V.N., Chernov, N.M. et al. Synthesis and Chromatographic Analysis of the Neuroprotective Agent Mafedine and Related Compounds. Russ J Gen Chem 91, 1661–1666 (2021). https://doi.org/10.1134/S1070363221090085
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070363221090085